Danaher traded at $211.76 this Thursday October 1st, decreasing $9.79 or 4.42 percent since the previous trading session. Looking back, over the last four weeks, Danaher lost 0.88 percent. Over the last 12 months, its price rose by 0.68 percent. Looking ahead, we forecast Danaher to be priced at 219.64 by the end of this quarter and at 205.71 in one year, according to Trading Economics global macro models projections and analysts expectations.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of instruments and consumables that are used by customers to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics, which offers analytical instruments, reagents, consumables, software and services, and Environmental & Applied Solutions, which offers products and services that help protect important resources and keep global food and water supplies safe. Its business research and development, manufacturing, sales, distribution, service and administrative facilities are located in over 60 countries.